The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States

Noninfectious pulmonary complications (NIPC) after allogeneic hematopoietic stem cell transplantation (alloHSCT), including bronchiolitis obliterans syndrome (BOS), cause significant morbidity and mortality, but their impact on health care resource utilization (HRU) and costs is unknown. This longit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacks, Naomi C., Healey, Bridget E., Raza, Sajjad, Cyr, Philip L., Boerner, Gerhard, Sheshadri, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Health Services and Outcomes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905687/
https://www.ncbi.nlm.nih.gov/pubmed/34807973
http://dx.doi.org/10.1182/bloodadvances.2021004364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905687/
https://www.ncbi.nlm.nih.gov/pubmed/34807973
http://dx.doi.org/10.1182/bloodadvances.2021004364

Ejemplares similares